Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

The latest announcement is out from Digi Power X ( ($TSE:DGX) ). Digi Power X Inc. has entered into an amended and restated at-the-market equity sa...

Digi Power X Updates US$75 Million ATM Program to Fund AI Data Center Expansion

Bernstein analyst Zhihan Ma maintained a Buy rating on Dollar General on April 6 and set a price target of $146.00. The company’s shares closed yes...

Bernstein Keeps Their Buy Rating on Dollar General (DG)

Markets closed the week with a cautious tone as oil, rates, and risk all moved higher. The S&P 500 (SPX) reached 6,582, while the Nasdaq (NDX) and ...

The Week That Was, The Week Ahead: Macro and Markets, April 5

RBC Capital analyst maintained a Buy rating on Dollar General yesterday. The company’s shares closed yesterday at $117.17. In addition to RBC Capit...

RBC Capital Sticks to Its Buy Rating for Dollar General (DG)

China Dongxiang (Group) Co ( ($HK:3818) ) has issued an update. China Dongxiang (Group) Co., Ltd. has appointed industry veteran Zhou Zhiyi as an i...

China Dongxiang appoints veteran consumer executive Zhou Zhiyi as independent non-executive director

China Dongxiang (Group) Co ( ($HK:3818) ) just unveiled an announcement. China Dongxiang has announced the current composition of its board of dire...

China Dongxiang Details Board Composition and Committee Roles

In a report released today, Joe Feldman from Telsey Advisory maintained a Hold rating on Dollar General, with a price target of $140.00. Feldman co...

Telsey Advisory Sticks to Its Hold Rating for Dollar General (DG)

Dollar General ( ($DG) ) has provided an update. Dollar General’s board on March 20, 2026 approved the hiring of grocery retail veteran Jerry W. “J...

Dollar General Announces CEO Succession and Leadership Transition

Evercore ISI analyst Michael Montani maintained a Hold rating on Dollar General today and set a price target of $150.00. According to TipRanks, Mon...

Evercore ISI Sticks to Its Hold Rating for Dollar General (DG)

In a report released today, Krisztina Katai from Deutsche Bank maintained a Buy rating on Dollar General, with a price target of $170.00. According...

Dollar General (DG) Gets a Buy from Deutsche Bank

In a report released yesterday, Zhihan Ma from Bernstein maintained a Buy rating on Dollar General, with a price target of $150.00. The company’s s...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$197.82	0.00%	718.36K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$197.82	0%	718.36K
3
4
5
6

DGX

DGX

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel